<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="ijms-21-03732-t002" orientation="portrait" position="float">
 <object-id pub-id-type="pii">ijms-21-03732-t002_Table 2</object-id>
 <label>Table 2</label>
 <caption>
  <p>Liquid biomarkers of NASH diseases.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References [ref]</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biomarker</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of Liquid Biopsy</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Application</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Disease</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Source</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample Type</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatology. 2016, Ibrahim, S.H. et al. [
     <xref rid="B63-ijms-21-03732" ref-type="bibr">63</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Toxic-Lipids and CYP2E1</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EVs</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prognostic Biomarker</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NASH</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatocyte</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell Supernatants/Mouse Model Serum</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clin Sci (Lond) 2017, Mridha, Haczeyni et al. [
     <xref rid="B69-ijms-21-03732" ref-type="bibr">69</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TLR9</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EVs</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diagnostic &amp; prognostic biomarker</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NASH</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatocytes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell supernatants</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">J Lipid Res 2016, Kakazu E. et al. [
     <xref rid="B75-ijms-21-03732" ref-type="bibr">75</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C16:0 ceramide and S1P</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EVs</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diagnosis &amp; monitoring biomarker</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NASH</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatocytes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mouse model Serum</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gastroenterology 2012, Kornek M. et al. [
     <xref rid="B32-ijms-21-03732" ref-type="bibr">32</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Levels</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Microparticles</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatic inflammation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NAFLD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serum/plasma</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">J Clin Invest 2016, Garcia-Martinez, Santoro et al. [
     <xref rid="B66-ijms-21-03732" ref-type="bibr">66</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">mtDNA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Microparticles</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diagnostic &amp; prognostic biomarkers</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NASH</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatocytes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plasma</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sci Rep. 2017, Yang RX. et al. [
     <xref rid="B52-ijms-21-03732" ref-type="bibr">52</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Triacylglycerol</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diagnosis biomarker</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NAFLD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serum</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">J Gastroenterol Hepatol. 2005, Gulsen, M. et al. [
     <xref rid="B57-ijms-21-03732" ref-type="bibr">57</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hcy</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Predictor biomarkers</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NAFLD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatocytes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">plasma</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gut. 2017, Hardy T. et al. [
     <xref rid="B55-ijms-21-03732" ref-type="bibr">55</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PPARγ</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DNA methylation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prognostic biomarker</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NAFLD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plasma</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Extracellular vesicles (EVs); cytochrome P450 2E1 (CYP2E1); mitochondrial DNA (mtDNA); non-alcoholic fatty liver disease (NAFLD); non-alcoholic steatohepatitis (NASH); peroxisome proliferator-activated receptor gamma (PPARγ); toll-like receptor 9 (TLR9); sphingosine 1 phosphate (S1P). homocysteine (Hcy); cytochrome P450 2E1 (CYP2E1); mitochondrial DNA (mtDNA); non-alcoholic fatty liver disease (NAFLD); non-alcoholic steatohepatitis (NASH); peroxisome proliferator-activated receptor gamma (PPARγ); toll-like receptor 9 (TLR9).</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
